Table II.
The clinicopathological parameters and expression of APOL1 protein for 135 patients with oral squamous cell carcinoma.
APOL1 expression, n | |||
---|---|---|---|
Clinicopathological parameter | High | Low | P-value |
Cancerous cases vs. non-cancerous cases | 0.001 | ||
Cancerous cases | 61 | 74 | |
Non-cancerous cases | 0 | 13 | |
Sex | |||
Male | 53 | 51 | 0.015 |
Female | 8 | 23 | |
Age, years | |||
≥60 | 24 | 31 | 0.728 |
<60 | 37 | 42 | |
Grade | |||
1–2 | 25 | 35 | 0.491 |
3–4 | 36 | 39 | |
Stage | |||
I–II | 25 | 35 | 0.491 |
III–IV | 36 | 39 | |
Pathological T | |||
T1-T2 | 43 | 15 | 0.840 |
T3-T4 | 59 | 18 | |
Pathological N | |||
N0 | 34 | 45 | 0.601 |
N1 | 27 | 29 | |
Pathological M | |||
M0 | 61 | 73 | 0.456 |
M1 | 0 | 1 |
APOL1, apolipoprotein L1; T, tumor; N, node; M, metastasis; Grade, clinical pathological grade; Stage, TNM stage.